Lytic replication of Epstein-Barr virus in the peripheral blood: Analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state

Blood

Volumn 89, Issue 5, 1997, Pages 1665-1677

  Prang, Nadja S ^b   Hornef, Mathias W ^b   Jäger, Michael ^b   Wagner, Hans J ^b   Wolf, Hans ^b   Schwarzmann, Fritz M ^a  

^a Uniklinik Regensburg   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL IMMORTALIZATION; CYTOTOXIC T LYMPHOCYTE; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; INFECTIOUS MONONUCLEOSIS; PRIORITY JOURNAL; PROGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; VIRUS CAPSID; VIRUS EXPRESSION; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 0031034593     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.5.1665     Document Type: Article

References (67)

1. Svedmyr E, Ernberg I, Seeley J, Weiland O, Masucci G: Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious monoucleosis. Clin Immunol Immunopathol 30:437, 1984
2. Okano M, Thiele GM, Davis JR, Grierson HL, Purtilo DT; Epstein-Barr virus and human diseases: Recent advances in diagnosis. Clin Microbiol Rev 1:300, 1988
3. Misko IS, Moss DJ, Pope JH: HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus. Proc Natl Acad Sci USA 77:4247, 1980
4. Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickinson A, Sissons JG: Epstein Barr virus-specific immune defects in patienfs with persistent symptoms following infectious mononuclesis. Q J Med 58:111, 1986
5. Blazar BA, Murphy AM: Induction of B cell responsiveness to growth factors by Epstein-Barr virus conversion: Comparison of endogenous factors and interleukin-1. Clin Exp Immunol 80:62, 1990
6. Tomkinson BE, Maziarz R, Sullivan JL: Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis. J Immunol 143:660, 1989
7. Finkelman FD, Holmes J, Katona IM, Urban JF Jr, Beckmann MP, Park LS, Schooley KA, Coffman RL, Mosmann TR, Paul WE: Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 8:303, 1990
8. Tosato G, Gerrard TL, Goldman NG, Pike SE: Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6. J Immunol 140:4329, 1988
9. Hornef MW, Wagner HJ, Kruse A, Kirchner H: Cytokine production in a whole-blood assay after Epstein-Barr virus infection in vivo. Clin Diagn Lab Immunol 2:209, 1995
10. Becker J, Leser U, Marschall M, Langford A, Jilg W, Gelderblom H, Reichart P, Wolf H: Expression of proteins encoded by Epstein-Barr virus tarns-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia. Proc Natl Acad Sci USA 88:8332, 1991
11. Straus SE, Komaroff AL, Wedner HJ: Chronic fatigue syndrome: Point and counterpoint. J Infect Dis 170:1, 1994
12. Okano M, Matsumoto S, Osato T, Sakiyama Y, Thiele GM, Purtilo DT: Severe chronic active Epstein-Barr virus infection syndrome. Clin Microbiol Rev 4:129, 1991
13. Burkitt DP: A study of cancer patterns in Africa. Sci Basis Med Annu Rev 1969:82
14. Wolf H, Hausen H, Becker V: EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature New Biol 244:245, 1973
15. Roth J, Daus H, Cause A, Trumper L, Pfreundschuh M: Detection of Epstein-Barr virus DNA in Hodgkin- and Reed-Sternberg-cells by single cell PCR. Leuk Lymphoma 13:137, 1994
16. Sixbey JW, Nedrud JG, Raab Traub N, Hanes RA, Pagano JS: Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 310:1225, 1984
17. Wolf H, Haus M, Wilmes E: Persistence of Epstein-Barr virus in the parotid gland. J Virol 51:795, 1984
18. Lemon SM, Hutt LM, Shaw JE, Li JL, Pagano JS: Replication of EBV in epithelial cells during infectious mononucleosis. Nature 268:268, 1977
19. Anagnostopoulos I, Hummel M, Kreschel C, Stein H: Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: Implications for the interindividual infection route of Epstein-Barr virus. Blood 85:744, 1995
20. Ring CJ: The B cell-immortalizing functions of Epstein-Barr virus. J Gen Virol 75:1, 1994
21. Wolf H, Bogedain C, Schwarzmann F: Epstein-Barr virus and its interaction with the host. Intervirology 35:26, 1993
22. Zur Hausen H, O'Neill FJ, Freese UK, Hecker E: Persisting oncogenic herpesvirus induced by the tumour promoter TPA. Nature 272:373, 1978
23. Miyashita EM, Yang B, Lam KM, Crawford DH, Thorley Lawson DA: A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80:593, 1995
24. Thorley-Lawson DA, Miyashita EM, Kahn G: Epstein-Barr Virus and the B-cell: That's all it takes. Trends Microbiol 4:204, 1996
25. Miller CL, Longnecker R, Kieff E: Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J Virol 67:3087, 1993
26. Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier LL: CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J Exp Med 175:353, 1992
27. Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ: Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: Implications for vaccine development. J Exp Med 176:169, 1992
28. Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB; Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): Implications for the immune control of EBV-positive malignancies. J Exp Med 176:157, 1992
29. Burrows SR, Misko IS, Sculley TB, Schmidt C, Moss DJ: An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants. J Virol 64:3974, 1990
30. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald Mullen PM, Klein G, Kurilla MG, Masucci MG: Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685, 1995
31. Schuster C, Chasserot Golaz S, Beck G: Activation of Epstein-Barr virus promoters by a growth-factor and a glucocorticoid. FEBS Lett 284:82, 1991
32. Defrance T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J: Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 175:671, 1992
33. + memory T cells contains performed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J Exp Med 181:1293, 1995
34. Cullen BR: Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol Rev 56:375, 1992
35. Lindahl T, Klein G, Reedman BM, Johansson B, Singh S: Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies. Int J Cancer 13:764, 1974
36. Taylor N, Countryman J, Rooney C, Katz D, Miller G: Expression of the BZLF1 latency-disrupting gene differs in standard and defective Epstein-Barr viruses. J Virol 63:1721, 1989
37. Takada K, Horinouchi K, Ono Y, Aya T, Osato T, Takahashi M, Hayasaka S: An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA. Virus Genes 5:147, 1991
38. Pulvertaft RJV: Cytology of Burkitt's tumor (African lymphoma). Lancet 1:238, 1965
39. Lear AL, Rowe M, Kurilla MG, Lee S, Henderson S, Kieff E, Rickinson AB: The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J Virol 66:7461, 1992
40. Farber I, Wutzler P, Wohlrabe P, Wolf H, Hinderer W, Sonneborn HH: Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombinant ELISAs. J Virol Methods 42:301, 1993
41. Futscher BW, Blake LL, Gerlach JH, Grogan TM, Dalton WS: Quantitative polymerase chain reaction analysis of mdr 1 mRNA in multiple myeloma cell lines and clinical specimens. Anal Biochem 213:414, 1993
42. Tierney RJ, Steven N, Young LS, Rickinson AB: EpsteinBarr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68:7374, 1994
43. Gaa YJ, Sullivan JL, Sixbey JW: Detection of cell-free Epstein-Barr virus DNA in serum during acute infectious mononucleosis. J Infect Dis 170:436, 1994
44. Sample J, Kieff E: Transcription of the Epstein-Barr virus genome during latency in growth-transformed lymphoccytes. J Virol 64:1667, 1990
45. Bogedain C, Wolf H, Modrow S, Stuber G, Jilg W: Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. J Virol 69:4872, 1995
46. Yamamoto M, Kimura H, Hironaka T, Hirai K, Hasegawa S, Kuzushima K, Shibata M, Morishima T: Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases. J Clin Microbiol 33:1765, 1995
47. Mellinghoff I, Daibata M, Humphreys RE, Mulder C, Takada K, Sairenji T: Early events in Epstein-Barr virus genome expression after activation: Regulation by second messengers of B cell activation. Virology 185:922, 1991
48. Katsuki T, Hinuma Y, Saito T, Yamamoto J, Hirashima Y, Sudoh H, Deguchi M, Motokawa M: Simultaneous presence of EBNA-positive and colony-forming cells in peripheral blood of patients with infectious mononucleosis. Int J Cancer 23:746, 1979
49. Klein G, Svedmyr E, Jondal M, Persson PO: EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients. Int J Cancer 17:21, 1976
50. Decker LL, Klaman LD, Thorley Lawson DA: Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J Virol 70:3286, 1996
51. Schaefer BC, Strominger JL, Speck SH: The Epstein-Barr virus BamHI F promoter is an early lytic promoter: Lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines. J Virol 69:5039, 1995
52. Gratama JW, Oosterveer MA, Zwaan FE, Lepoutre J, Klein G, Ernberg I: Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: Implications for sites of viral latency. Proc Natl Acad Sci USA 85:8693, 1988
53. Gratama JW, Oosterveer MA, Lepoutre J, Fibbe WE, Ringden O, Vossen JM, Willemze R, Bolhuis RL, van Rood JJ, Ernberg I: Epstein-Barr virus infection in allogeneic marrow grafting: Lessons for transplant physicians and virologists. Ann Hematol 64:A162, 1992 (suppl)
54. Prang N, Wolf H, Schwarzmann F: Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1. J Virol 69:2644, 1995
55. Cochet C, Martel Renoir D, Grunewald V, Bosq J, Cochet G, Schwaab G, Bernaudin JF, Joab I: Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells. Virology 197:358, 1993
56. Schwarzmann F, Prang N, Reichelt B, Rinkes B, Haist S, Marschall M, Wolf H: Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1. J Gen Virol 75:1999, 1994
57. Montalvo EA, Shi Y, Shenk TE, Levine AJ: Negative regulation of the BZLF1 promoter of Epstein-Barr virus. J Virol 65:3647, 1991
58. Montalvo EA, Cottam M, Hill S, Wang YJ: YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter. J Virol 69:4158, 1995
59. Flemington E, Speck SH: Epstein-Barr virus BZLF1 trans activator induces the promoter of a cellular cognate gene, c-fos. J Virol 64:4549, 1990
60. Flemington E, Speck SH: Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol 64:1217, 1990
61. Furnari FB, Zacny V, Quinlivan EB, Kenney S, Pagano JS: RAZ, an Epstein-Barr virus transdominant represser that modulates the viral reactivation mechanism. J Virol 68:1827, 1994
62. Gutsch DE, Holley Guthrie EA, Zhang Q, Stein B, Blanar MA, Baldwin AS, Kenney SC: The bZIP transactivator of Epstein-Barr viras, BZLF1. functionally and physically interacts with the p65 subunit of NF-kappa B. Mol Cell Biol 14:1939, 1994
63. Zhang Q, Gutsch D, Kenney S: Functional and physical interaction between p53 and BZLF1: Implications for Epstein-Barr virus latency. Mol Cell Biol 14:1929, 1994
64. Daibata M, Humphreys RE, Sairenji T: Phosphorylation of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA. Virology 188:916, 1992
65. Hsu DH, de Waal Malefyt R, Fiorentino DF, Dang MN, Vieira P, de Vries J, Spits H, Mosmann TR, Moore KW: Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250:830, 1990
66. Sixbey JW, Yao QY: Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 255:1578, 1992
67. Bayliss GJ, Wolf H: An Epstein-Barr virus early protein induces cell fusion. The regulated expression of Epstein-Barr virus. III. Proteins specified by EBV during the lytic cycle Epstein-Barr virus-induced cell fusion. Nature 287:164, 1980